1. Challenges and Opportunities in Dose Finding in Oncology and Immuno‐oncology. Issue 4 (1st February 2018) Authors: Ji, Yan; Jin, Jin Y.; Hyman, David M.; Kim, Geoffrey; Suri, Ajit Journal: Clinical and translational science Issue: Volume 11:Issue 4(2018) Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dose dependence of treatment-related adverse events for immune checkpoint inhibitor therapies: a model-based meta-analysis. (1st January 2020) Authors: Shulgin, Boris; Kosinsky, Yuri; Omelchenko, Andrey; Chu, Lulu; Mugundu, Ganesh; Aksenov, Sergey; Pimentel, Rodrigo; DeYulia, Garrett; Kim, Geoffrey; Peskov, Kirill; Helmlinger, Gabriel Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dose dependence of treatment-related adverse events for immune checkpoint inhibitor therapies: a model-based meta-analysis. (1st January 2020) Authors: Shulgin, Boris; Kosinsky, Yuri; Omelchenko, Andrey; Chu, Lulu; Mugundu, Ganesh; Aksenov, Sergey; Pimentel, Rodrigo; DeYulia, Garrett; Kim, Geoffrey; Peskov, Kirill; Helmlinger, Gabriel Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Enrollment of older adults on oncology trials: An FDA perspective. Issue 3 (May 2017) Authors: Singh, Harpreet; Beaver, Julia A.; Kim, Geoffrey; Pazdur, Richard Journal: Journal of geriatric oncology Issue: Volume 8:Issue 3(2017) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum‐Containing Chemotherapy. (19th April 2017) Authors: Ning, Yang‐Min; Suzman, Daniel; Maher, V. Ellen; Zhang, Lijun; Tang, Shenghui; Ricks, Tiffany; Palmby, Todd; Fu, Wentao; Liu, Qi; Goldberg, Kirsten B.; Kim, Geoffrey; Pazdur, Richard Journal: Oncologist Issue: Volume 22:Number 6(2017) Page Start: 743 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum‐Containing Chemotherapy. (June 2017) Authors: Ning, Yang‐Min; Suzman, Daniel; Maher, V. Ellen; Zhang, Lijun; Tang, Shenghui; Ricks, Tiffany; Palmby, Todd; Fu, Wentao; Liu, Qi; Goldberg, Kirsten B.; Kim, Geoffrey; Pazdur, Richard Journal: Oncologist Issue: Volume 22:Number 6(2017) Page Start: 743 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FDA Approval Summary: Nivolumab in Advanced Renal Cell Carcinoma After Anti‐Angiogenic Therapy and Exploratory Predictive Biomarker Analysis. (23rd February 2017) Authors: Xu, James Xunhai; Maher, V. Ellen; Zhang, Lijun; Tang, Shenghui; Sridhara, Rajeshwari; Ibrahim, Amna; Kim, Geoffrey; Pazdur, Richard Journal: Oncologist Issue: Volume 22:Number 3(2017) Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FDA Approval Summary: Nivolumab in Advanced Renal Cell Carcinoma After Anti‐Angiogenic Therapy and Exploratory Predictive Biomarker Analysis. (March 2017) Authors: Xu, James Xunhai; Maher, V. Ellen; Zhang, Lijun; Tang, Shenghui; Sridhara, Rajeshwari; Ibrahim, Amna; Kim, Geoffrey; Pazdur, Richard Journal: Oncologist Issue: Volume 22:Number 3(2017) Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Proteomic Profiling in Ovarian Cancer. (1st November 2009) Authors: Kim, Geoffrey; Minig, Lucas; Kohn, Elise C. Journal: International journal of gynecological cancer Issue: Volume 19(2009)Supplement 2 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. U.S. Food and Drug Administration Approval Summary: Enzalutamide for the Treatment of Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer. (12th June 2015) Authors: Ning, Yang-Min; Brave, Michael; Maher, V. Ellen; Zhang, Lijun; Tang, Shenghui; Sridhara, Rajeshwari; Kim, Geoffrey; Ibrahim, Amna; Pazdur, Richard Journal: Oncologist Issue: Volume 20:Number 8(2015) Page Start: 960 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗